Saturna Capital’s CVS Health CVS Stock Holding History

Saturna Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,200	Closed	-$635K	–	157
2018 Q1	$635K	Hold	10,200	–	–	0.02%	118
2017 Q4	$740K	Sell	10,200 -4,665	-31%	-$339K	0.02%	115
2017 Q3	$1.08M	Hold	14,865	–	–	0.04%	98
2017 Q2	$1.2M	Buy	14,865 +1,830	+14%	+$144K	0.04%	98
2017 Q1	$1.02M	Hold	13,035	–	–	0.03%	103
2016 Q4	$1.03M	Hold	13,035	–	–	0.04%	103
2016 Q3	$1.16M	Sell	13,035 -37	-0.3%	-$3.49K	0.04%	102
2016 Q2	$1.25M	Sell	13,072 -2,358	-15%	-$235K	0.04%	99
2016 Q1	$1.6M	Hold	15,430	–	–	0.05%	98
2015 Q4	$1.51M	Buy	15,430 +363	+2%	+$35.6K	0.05%	111
2015 Q3	$1.45M	Buy	15,067 +3,881	+35%	+$408K	0.05%	113
2015 Q2	$1.22M	Hold	11,186	–	–	0.03%	123
2015 Q1	$1.16M	Hold	11,186	–	–	0.03%	126
2014 Q4	$1.08M	Hold	11,186	–	–	0.03%	131
2014 Q3	$890K	Hold	11,186	–	–	0.02%	146
2014 Q2	$843K	Hold	11,186	–	–	0.02%	145
2014 Q1	$837K	Buy	11,186 +1,186	+12%	+$83.8K	0.02%	143
2013 Q4	$716K	Hold	10,000	–	–	0.02%	164
2013 Q3	$568K	Hold	10,000	–	–	0.02%	181
2013 Q2	$572K	Buy	+10,000	New	+$579K	0.02%	174

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Saturna Capital's CVS Position: Q2 2018 in Review

Saturna Capital sold out of CVS Health (CVS) in Q2 2018, closing a stake of 10,200 shares — an estimated $635K sold.

Saturna Capital first reported a position in CVS in Q2 2013 and held it in 20 quarters. The position peaked at $1.6M in Q1 2016. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

Saturna Capital reported no remaining CVS Health position as of Q2 2018 after selling out during the quarter.
Saturna Capital sold 10,200 CVS Health shares in Q2 2018, an estimated $635K.
Saturna Capital first reported a position in CVS Health in Q2 2013 and held it in 20 quarters.
Saturna Capital's CVS Health position peaked at $1.6M in Q1 2016.
1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Saturna Capital's 13F filing for Q2 2018, filed 2 Aug 2018.